Skip to main content
. Author manuscript; available in PMC: 2013 Aug 28.
Published in final edited form as: World J Emerg Med. 2012 Jun 12;3(2):102–107. doi: 10.5847/wjem.j.issn.1920-8642.2012.02.004

Figure 1.

Figure 1

Represents the assessment of subjects for eligibility for the study. Of 393 screened subjects, 96 were eligible, 27 were excluded because they did not have complete information or vancomycin was not ordered. Six additional subjects were excluded because they were ineligible for EGDT. A total of 63 patients were analyzed. EGDT: early goal directed therapy.